Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Cash & Current Investments (2023 - 2025)

Hinge Health's Cash & Current Investments history spans 3 years, with the latest figure at $363.9 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 22.01% year-over-year to $363.9 million; the TTM value through Dec 2025 reached $363.9 million, down 22.01%, while the annual FY2025 figure was $363.9 million, 22.01% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $363.9 million at Hinge Health, down from $432.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $466.6 million in Q4 2024 and bottomed at $235.0 million in Q4 2023.
  • The 3-year median for Cash & Current Investments is $363.9 million (2025), against an average of $345.1 million.
  • The largest annual shift saw Cash & Current Investments surged 98.58% in 2024 before it fell 22.01% in 2025.
  • A 3-year view of Cash & Current Investments shows it stood at $235.0 million in 2023, then skyrocketed by 98.58% to $466.6 million in 2024, then dropped by 22.01% to $363.9 million in 2025.
  • Per Business Quant, the three most recent readings for HNGE's Cash & Current Investments are $363.9 million (Q4 2025), $432.6 million (Q3 2025), and $413.3 million (Q2 2025).